Abstract: OS Fund invests in entrepreneurs commercializing breakthrough discoveries in genomics, synthetic biology, artificial intelligence, precision automation, and new materials development. We never look to invest in a single molecule, model or algorithm. We instead seek out enabling technologies and the platform they power. The companies we believe will be disproportionately successful are building tools that lower barriers to discovery in our specific areas of focus, helping decrease the overall risk of pursuing breakthroughs in the process.
Our portfolio companies develop their own IP to bring technologies to market that solve real-world challenges. They also have a business model that enables further discovery not just for themselves but for the surrounding ecosystem too. When these characteristics are present, we invest with high conviction early in the company’s life, and remain closely involved thereafter. We partner with entrepreneurs who are working towards quantum-leap discoveries that promise to rewrite the operating systems of life.
Node: Bryan Johnson, Jeff Klunzinger